Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | PTGES2 | Q9H7Z7 | 10/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7663530 | 0.76 | ALDH1A1 (0.59) | ALDH1A1HTTLMNAKMT2APKM | |
| SCHEMBL7248225 | 0.74 | C1S (0.53) | ALDH1A1HTTPTGES2 | |
| SCHEMBL7665091 | 0.72 | ALDH1A1 (0.47) | ALDH1A1KMT2A | |
| SCHEMBL7248655 | 0.69 | SLC40A1 (0.45) | ALDH1A1PKM | |
| SCHEMBL1122427 | 0.69 | KMT2A (0.77) | ALDH1A1HTTPTGES2LMNAKMT2A | |
| SCHEMBL1122431 | 0.69 | KMT2A (0.77) | ALDH1A1HTTPTGES2LMNAKMT2A | |
| SCHEMBL15176784 | 0.68 | ALDH1A1 (0.59) | ALDH1A1HTTPTGES2LMNAKMT2A | |
| SCHEMBL7525628 | 0.67 | HTT (0.57) | ALDH1A1HTTPTGES2LMNAKMT2A | |
| SCHEMBL13889749 | 0.67 | HTT (0.57) | ALDH1A1HTTPTGES2LMNAKMT2A | |
| SCHEMBL12851366 | 0.67 | HTT (0.57) | ALDH1A1HTTPTGES2LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6562840-B1 | Non-peptidic inhibitors of proteolytic enzymes such as urokinase | 3-DIMENSIONAL PHARMACEUTICALS, INC. | 2003-05-13 | — | — | US | disclosed |